Downregulation of Metabolic Gene Expression in Failing Human Heart before and after Mechanical Unloading
- 1 July 2002
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 97 (4) , 203-209
- https://doi.org/10.1159/000063122
Abstract
Background: We have previously shown that several metabolic genes are downregulated in the failing human heart. We now tested the hypothesis that mechanical unloading might reverse this process. Methods: Clinical data and myocardial tissue were collected from 14 failing hearts paired for the time of implantation and explantation of a left ventricular assist device (LVAD) and compared to 10 non-failing hearts. Transcript levels for key regulators of energy metabolism and for atrial natriuretic factor (ANF) were measured by real-time quantitative RT-PCR. Results: The expression of the glucose transporter 1 and 4 (GLUT1, GLUT4), muscle carnitine palmitoyl transferase-1 (mCPT-1), and uncoupling protein 3 (UCP3) were downregulated by up to 80% in the failing heart. Although LVAD treatment improved clinical markers of heart failure (decrease of left ventricular diastolic dimension and normalization of serum sodium), only UCP3 expression reversed to non-failing transcript levels following mechanical unloading. Conclusions: LVAD treatment only partially reverses depressed metabolic gene expression in the failing human heart. Reversal of depressed UCP3 expression may be an important mechanism for reducing the formation of oxygen-derived free radicals. Further studies are necessary to define the effects of mechanical unloading on post-transcriptional mechanisms.This publication has 4 references indexed in Scilit:
- Myocardial tumor necrosis factor–α expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device supportThe Annals of Thoracic Surgery, 2001
- Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heartThe FASEB Journal, 2001
- Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophyNature Medicine, 1998
- Transplantation as a primary treatment for hypoplastic left heart syndrome: Intermediate-term resultsThe Annals of Thoracic Surgery, 1996